HCMSG The Hepatitis C Mentor & Support Group, Inc.
Search
  • Home
  • About Us
    • Our Mission
    • Board of Directors
  • Resources
    • Hep C Facts & Stats
    • Patient Assistance Programs
    • Research and Publications
    • Reading
    • Links
  • Programs/Training
    • The Hepatitis C Education and Support Group Assistance Program
    • The Circle Model >
      • THE CIRCLE Registration
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
  • Contact Us

DOCTORS PUSH TO SCREEN BABY BOOMERS FOR HEPATITIS C

10/31/2013

1 Comment

 

Advances in Testing and Treating the Liver Disease
Prompt Change in Tactics 


By         Joseph Walker               
 Oct. 28, 2013 6:59 p.m. ET

 For millions of healthy,
clean-living Baby Boomers, visiting the doctor in coming years could result in a
surprising request that they be tested for hepatitis C. Joseph Walker explains
why on Lunch Break. Photo: Getty Images.                              



Millions of healthy baby boomers may get a surprising request at future
doctor visits: Get tested for hepatitis C, the potentially fatal liver virus
commonly thought to affect mostly intravenous drug users.


A small minority of boomers are thought to suffer from the disease. But
momentum is building to have more than 60 million screened because of easier
testing methods and less harmful and more effective treatment, including a drug
that could be cleared for sale in the U.S. at the end of this year.


Called a "silent epidemic," hepatitis C affects roughly 3.2 million people in
the U.S., though at least half of those infected don't know it, health officials
say. Often, symptoms don't appear until dangerous complications like cirrhosis
or cancer have already occurred. The Centers for Disease Control and Prevention
attributes 16,600 deaths to hepatitis C in 2010, the most recent year for which
data is available. Many could have been avoided had patients been diagnosed and
treated earlier.


Boomers—people born in the U.S. between 1945 and 1965, as defined by the
CDC—are more likely to suffer from hepatitis C than others. The reasons: high
rates of experimental drug use in the 1960s and 1970s, and lack of oversight
given to the blood supply used in all transfusions before 1992, officials say.
Boomers, now in their late 40s to late 60s, may not realize they have been
exposed to potentially infected blood.








Enlarge Image        
              
             
                        
                                 
                     Cheryl Moch, 63, in Brooklyn,
N.Y., was diagnosed with hepatitis C in 1997 and cleared of the virus in 2010.  
                    Brian Harkin for The Wall Street Journal        
 "Surprisingly enough, many people may not know if they had a blood
transfusion even if they know they had a car accident and went to the hospital
decades ago," said Michael LeFevre, professor of family medicine at the
University of Missouri.


The U.S. Preventive Services Task Force, an influential medical guidelines
body, recommended in June that people born between 1945 and 1965 be offered
screenings. Under the Affordable Care Act, the recommendation means that most
private health insurers must now pay the full costs of screening at no
out-of-pocket cost to patients. State Medicaid programs that cover the cost of
screenings recommended by the task force receive extra funding under the
ACA.


The price of initial hepatitis C testing ranges up to $200 and additional
tests may be required.


          UnitedHealth Group
Inc.,                     
UNH +0.75%
                           UnitedHealth Group Inc.           
           U.S.: NYSE          
   $68.52               +0.51+0.75%            
              Oct 31, 2013 2:22 pm            
    Volume (Delayed 15m)                :                    1.83M  
                                                            
                         P/E
Ratio                 12.93                                 
     Market Cap            $69.15 Billion        
                                                        Dividend Yield               1.64%
                                       Rev. per Employee               $903,361       
                                                  
              69.0068.5068.0067.5010a11a12p1p2p3p    
                             10/29/13 Artificial Intelligence ay
Red...
             10/25/13 White House Sets
Late-November...
             10/23/13 Contractors Point Fingers
Over...
             More quote details and news
»
                                 UNH in    
                                                     
                Your
Value                 Your Change          
                                    
                                
                   
                              Short position  
                                 
                                                 the largest U.S.
health insurer by revenue, began covering the test after the task force's
recommendation, a company spokeswoman said. The Centers for Medicare and
Medicaid Services also may add coverage for testing because of the task force's
recommendation, a spokesman said. A decision is expected in June.




             
A Stealthy Disease
The facts about hepatitis C:


 


  • Hepatitis C is a viral infection that can create liver inflammation.

  • History of intravenous drug use or blood transfusions are the biggest risk
    factors.

  • Approximately 3.2 million people carry the virus in the U.S.

  • Roughly 16,600 deaths were attributed to hepatitis C in 2010.

  • As many as 20% of those infected with chronic hepatitis C will develop
    cirrhosis.

  • Screening of those born between 1945 and 1965 could detect 800,000
    additional cases.



Source: Centers for Disease Control and Prevention


Meanwhile, New York last week became the first state to enact a law requiring
that boomers be offered screening when they see a doctor or enter the
hospital.


"If you test negative, you can have peace of mind that you aren't infected,"
said                                     John Ward,                             
    director of the division of viral hepatitis at the CDC. "If you are positive,
you can get the care you need."


Even some physicians who plan to follow the task force's recommendation said
they worry it could become burdensome. Doctor visits tend to be short, and older
patients can have a raft of health risks that require attention.


"I'm not against it, but every time I see patients, I feel the pressure of
this list of things we're supposed to do," said                                 
    Molly Cooke,                                 president of the American
College of Physicians.


Ensuring that optional screening is offered to patients will be a challenge,
health officials acknowledge. Electronic medical records may help. Physicians at
Beth Israel Deaconess Medical Center in Boston now receive computerized alerts
prompting them to offer testing for unscreened boomers. The number of boomers
tested at the hospital has tripled since June to 1,200 per month, said          
                           Camilla S. Graham,                                 a
physician there.


With increased screening, however, comes the risk that many people will
receive expensive, unneeded treatment or suffer undue pain through testing
procedures. The majority of people with hepatitis C will never suffer liver
damage and ultimately die of other causes. Until recently, that kept officials
from recommending screening to people without known risk factors, such as
sharing needles during drug use or having received blood transfusions or organ
transplants before 1992. It's possible to contract the disease through sex,
though uncommon.


Advances in treatment and minimally invasive diagnostics have started to
change the risk-benefit calculation. In the past, biopsies were common for
people who tested positive for the virus. The procedure can cause severe pain,
bleeding or infection in 1% of patients and, more rarely, death. Liver biopsies
have become less common with the development of blood tests capable of detecting
liver scarring.


Meanwhile, the long treatment durations and severe side effects associated
with standard therapies could be reduced in the coming years with an
experimental pill developed by                                
         Gilead Sciences Inc.   
                 
  GILD
-1.03%
                  
         Gilead Sciences
Inc.
                      U.S.: Nasdaq             $71.92            
   -0.75-1.03%   
                       Oct 31, 2013 2:22 pm   
             Volume (Delayed 15m)                :                   
7.84M                                                
                         
              P/E Ratio                 36.11                
                      Market Cap           
$111.48 Billion                                                 
               Dividend Yield              
N/A                                      Rev.
per Employee               $2,128,200                       
                                   
             73727110a11a12p1p2p3p    
                             10/29/13 Gilead Profit Rises on Sales
G...
             10/25/13 Pricey, Volatile Biotech
Stock...
             More quote details and news
»
                                 GILD in   
                                                      
                Your
Value                 Your Change          
                                    
                                
                   
                              Short position  
                                 
                                                 called sofosbuvir.
The treatment received a unanimous approval recommendation from an advisory
committee last Friday and could be cleared for sale in the U.S. by December.


This therapy could eventually eliminate the need to use interferon, an
injectable drug that is the most toxic part of current regimens, and cure some
patients in as few as three months. Approval would follow the approval of drugs
called protease inhibitors in 2011 for hepatitis C that cut treatment times in
half for some patients, from about a year to under six months.


                                      Cheryl Moch,                            
     a New York City social worker, waited 12 years after testing positive to
undergo treatment. Annual sonograms showed that her liver was healthy, but a few
years ago she decided the inconvenience of treatment was worth the relief of
having the virus cleared from her system.


"I could've gone to my grave without ever developing liver failure or
cancer," said Ms. Moch, now 63 years old. "But I didn't want to have this
hanging over me."


Write to Joseph Walker at Joseph.Walker@wsj.com

1 Comment

A TRIBUTE TO ARLINE LOH

10/19/2013

0 Comments

 
She was a Wonderful Warrior who never gave up. She talked the talk, but more importantly, "walked the walk".
Her work must must be passed forward. She would want that.
Arline, you will never be forgotten!

AS WRITTEN BY HER FAMILY- Arline Loh (January 16 1949- October 15 2013)

Arline Loh, 64, of Toronto Ontario, passed away peacefully at the Hospital at University at Pennsylvania
on October 15, 2013 surrounded by her husband and children.

Born January 16, 1949 in Shanghai, China, she was the daughter of Chin Chi and Jun Jiang Ding.

Arline led a successful career at Scotiabank and ING Direct as a banking IT expert before retiring and
becoming an advocate for Hepatitis B. She was recognized in 2013 as a White House Champion of Change
for her pioneering volunteer work as the co-founder of H+EAL (Health and Education for Asian Livers)

Loving wife of 41 years to Danny. Cherished mother of Lisa and her husband, Roy Watson, Anthony and wife, Jenny,
and Christina and husband Tom Johnston. Beloved grandmother of Delaney, Makenna and Emma. Caring sister of Julie
(Frank Ni) Ming Ping, and James (Kelly). Arline will also be missed by her Aunts Grace and Elizabeth. She is predeceased by her brother Nianzu, and uncle Abe (Connie). She will also be missed by nieces, cousins, and many friends.

In her life Arline touched the lives of many. She will be long be remembered for her strength, determination, generosity
and unwavering love of family. She will be truly missed by many and is nan immense loss to all those that knew her.

The family nwould like to extend their heartfelt thanks to the staff at the hospital at UPENN. A special thank you to Anita,
Mike, Amanda for being such loving caregivers and advocates for Arline throughout her last six weeks in the SICU.
Cremation has taken place. At Arline's request in lieu of a visitation, a memorial celebrating her life will be held on her
birthday January 16, 2014 in Toronto, Ontario.

If desired, in Arline's memory, donations may be made to her Hepatitis B advocacy project, H+EAL, which will see to it that her vision for the program is met. Please make donations in her honour through www.hepb.org
Please feel free to forward along as you see fit.

Thank you so very much for being a part of our mother's life. She was so proud of us, her children, but it is us that are in awe of her spirit, successes, and vivacity.

Yours,
Danny, Lisa, Anthony and Christine Loh




0 Comments

    Archives

    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy